A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS for children and adults living with Lennox–Gastaut syndrome (LGS).
A recent study, published in the journal Nature looked into the six-month impact of switching neovascular age-related macular degeneration and diabetic macular oedema patients to faricimab instead of anti-VEGF therapy.
Lorna Rothery spoke to Dr Cathy Price, Associate Professor in Pain Management and Vice President of the British Pain Society, about the difficulties in diagnosing, treating, and managing chronic pain.
Lorna Rothery interviewed Dr Lauren Sorce, PhD, RN, CPNP-AC/PC, FCCM, President of the Society of Critical Care Medicine and Co-chair of the Surviving Sepsis Campaign, to discuss the challenges of diagnosing and treating sepsis.
Researchers led by Maryam Shanechi at the USC Center for Neurotechnology have revealed an AI algorithm that could change the way we understand our brain activity and its applications in medical technology.
As Emergency Departments face increasing pressure, more patients are being redirected for minor injuries. While this eases the burden, missed fractures are on the rise, causing the NHS to lose millions in misdiagnosis costs.
Researchers have unveiled a pioneering method that could revolutionise the early detection of pancreatic cancer, a disease known for its late diagnosis and low survival rates.
A new study led by researchers at University College London (UCL) suggests that routine blood tests could significantly enhance early cancer diagnosis for individuals experiencing stomach pain or bloating.
Among the excitement of summer, it’s crucial to stay informed about how the season can affect our health, particularly when it comes to medications and medical devices.
Researchers from UCL and Moorfields Eye Hospital have identified potential markers in the blood that could change the treatment of glaucoma, a leading cause of irreversible blindness worldwide.
New research highlights a crucial consideration for men battling prostate cancer, a potentially heightened risk of heart disease when certain medications are combined.
Associate Professor Ailsa McGregor from the University of Otago's School of Pharmacy has set on a mission to enhance the efficacy and safety of lithium treatment for patients battling bipolar disorder (BD).
